Abstract:Tuberculosis, disease caused by Mycobacterium tuberculosis, is currently the leading cause of death by a single infectious agent worldwide. Early, rapid and accurate identification of M. tuberculosis and the determination of drug susceptibility is essential for the treatment and management of this disease. Tuberculosis diagnosis is mainly based on chest radiography, smear microscopy and bacteriological culture. Smear microscopy has variable sensitivity, mainly in patients co-infected with the human immunodeficiency virus (HIV). Conventional culture for M. tuberculosis isolation, identification and drug susceptibility testing requires several weeks owning to the slow growth of M. tuberculosis. The delay in the time to results drives the prolongation of potentially inappropriate antituberculosis therapy contributing to the emergence of drug resistance, reducing treatment options and increasing treatment duration and associated costs, resulting in increased mortality and morbidity. For these reasons, novel diagnostic methods are need for timely identification of M. tuberculosis and determination of the antibiotic susceptibility profile of the infecting strain. Molecular methods offer enhanced sensitivity and specificity, early detection and the capacity to detect mixed infections. These technologies have improved turnaround time, cost effectiveness and are amenable for point-of-care testing. However, although these methods produce results within hours from sample collection, the phenotypic susceptibility testing is still needed for the determination of drug susceptibility and quantify the susceptibility levels of a given strain towards individual antibiotics. This review presents the history, advances and forthcoming promises in the molecular diagnosis of tuberculosis. An overview on the general principles, diagnostic value and the main advantages and disadvantages of the molecular methods used for the detection and identification of M. tuberculosis and its associated disease, is provided. It will be also discussed how the current phenotypic methods should be used in combination with the genotypic methods for rapid antituberculosis susceptibility testing.

Single-cell sequencing: Current applications in various tuberculosis specimen types.

Single‐Cell Sequencing Reveals Functional Alterations in Tuberculosis

Current applications of next-generation sequencing technology in Mycobacterium tuberculosis research

Progress in the application of whole genome sequencing in tuberculosis research

Current landscape of exosomes in tuberculosis development, diagnosis, and treatment applications

Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas

Tuberculosis-targeted next-generation sequencing and machine learning: An ultrasensitive diagnostic strategy for paucibacillary pulmonary tuberculosis and tuberculous meningitis

Single-cell Transcriptomics of Blood Reveals a Natural Killer Cell Subset Depletion in Tuberculosis

Landscape of Exhausted T Cells in Tuberculosis Revealed by Single-Cell Sequencing

[Application of Whole Genome Sequencing Technology in the Epidemiology of Tuberculosis].

Cost-Effective Whole Transcriptome Sequencing Landscape and Diagnostic Potential Biomarkers in Active Tuberculosis

Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq

Tuberculosis: Current state of knowledge: An Epilogue

Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development

Evaluation of targeted sequencing for pathogen identification in bone and joint infections: a cohort study from China

Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance

Characteristics of alveolar macrophages in bronchioalveolar lavage fluids from active tuberculosis patients identified by single-cell RNA sequencing

RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent Mycobacterium Tuberculosis Infection.

An overview of next generation sequencing strategies and genomics tools used for tuberculosis research

Single-cell RNA-sequencing reveals heterogeneity and intercellular crosstalk in human tuberculosis lung

Advances in the molecular diagnosis of tuberculosis: From probes to genomes